Buyback of Class B shares in Essity during week 34, 2025

Between August 18, 2025, and August 22, 2025, Essity Aktiebolag (publ) repurchased a total of 390,489 own Class B shares (ISIN: SE0009922164) under the framework of the buyback program as resolved by the Board of Directors.

The share purchase is part of the SEK 3bn buyback program announced by Essity on April 23, 2025. The buyback program will extend from April 24, 2025, until the 2026 Annual General Meeting and be implemented in accordance with the EU Market Abuse Regulation (MAR) and the European Commission’s Delegated Regulation 2016/1052 (Safe Harbour Regulation).

The share repurchase is financed using cash flow from current operations after the ordinary dividend with the ambition to continue with share buybacks over time as a recurring part of Essity’s capital allocation.

Class B shares in Essity were repurchased as follows:

Date
Aggregated daily volume (no. of shares):
Weighted average price per day (SEK):
Total daily transaction value (SEK):
August 18, 2025
71,907
249.5473
17,944,198
August 19, 2025
72,534
251.4808
18,240,908
August 20, 2025
80,584
254.4406
20,503,841
August 21, 2025
82,810
254.0099
21,034,560
August 22, 2025
82,654
255.3772
21,107,947
Total accumulated during week 34 2025
390,489
253.0966
98,831,454
Total accumulated during the buyback program
5,349,448
260.9014
1,395,678,258

All purchases were conducted on Nasdaq Stockholm by BofA Securities Europe SA on behalf of Essity. Following the above purchases, Essity’s holding of treasury shares amounted on August 22, 2025, to 6,131,948 Class B shares. The total number of shares in Essity amounted on the date of this press release to 693,054,489, of which 58,973,654 Class A shares and 634,080,835 Class B shares.    

Essity is a global, leading hygiene and health company. Every day, our products, solutions and services are used by a billion people around the world. Our purpose is to break barriers to well-being for the benefit of consumers, patients, caregivers, customers and society. Sales are conducted in approximately 150 countries under the leading global brands TENA and Tork, and other strong brands such as Actimove, Cutimed, JOBST, Knix, Leukoplast, Libero, Libresse, Lotus, Modibodi, Nosotras, Saba, Tempo, TOM Organic and Zewa. In 2024, Essity had net sales of approximately SEK 146bn (EUR 13bn) and employed 36,000 people. The company’s headquarters is located in Stockholm, Sweden and Essity is listed on Nasdaq Stockholm. More information at essity.com.

For further information, please contact:
Sandra Åberg, Vice President Investor Relations, +46 70 564 96 89, sandra.aberg@essity.com

Läs mer på Cision

Ämnen i artikeln


Essity B

Senast

244,20

1 dag %

−1,61%

1 dag

1 mån

1 år

Marknadsöversikt

1 DAG %

Senast

1 mån